Clinical Trial Update: Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating autologous tumor lysate-pulsed D-CIK cells combined with chemotherapy for gastric cancer; the study status is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Autologous tumor lysate-pulsed D-CIK cells (D-CIK with autologous tumor lysate)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Gastric Cancer, Neoplasms | Phase 2 | Status: UNKNOWN